SEARCH
検索詳細小林 雄太 (コバヤシ ユウタ)
| 北海道大学病院 内科 | 助教 |
研究者基本情報
■ 学位■ URL
researchmap URLホームページURL■ ID 各種
J-Global ID■ 研究キーワード・分野
研究キーワード研究分野■ 担当教育組織
経歴
■ 経歴経歴
- 2026年01月 - 現在
北海道大学病院, 循環器内科, 診療講師 - 2025年04月 - 2025年12月
北海道大学病院, 循環器内科, 助教 - 2023年04月 - 2025年03月
仙台厚生病院, 循環器内科, 医師 - 2023年04月 - 2025年03月
北海道大学大学院 医学研究院, 循環病態内科学教室, 客員研究員 - 2022年04月 - 2023年03月
北海道大学大学院 医学研究院, 循環病態内科学教室, 特任助教 - 2018年04月 - 2022年03月
北海道大学大学院 医学研究院, 循環病態内科学教室, 医員 - 2017年04月 - 2018年03月
苫小牧市立病院循環器内科 - 2015年04月 - 2017年03月
市立札幌病院循環器内科 - 2013年04月 - 2015年03月
市立函館病院初期研修医
研究活動情報
■ 受賞- 2025年, 第15回日本経カテーテル心臓弁治療学会学術集会 JTVT 2025, YIA優秀賞
- 2024年, ストラクチャークラブジャパンライブデモンストレーション2024 Young Investigator Award 最優秀賞 TAVI部門
- 2022年, 第41回 北海道大学 高桑栄松奨学基金奨励賞
- 2020年, 第16回 音羽博次奨学基金奨学基金 受賞
- 2020年, 第68回 日本心臓病学会 YIA優秀賞
- 2019年, 一般財団法人 北海道心臓協会, 研究開発調査助成賞受賞
- 2019年, 公益財団法人 伊藤医薬学術交流財団, 第25回海外交流助成賞
- 2016年, 第116回 日本循環器学会北海道地方会 臨床研究部門 YIA最優秀賞受賞
- Hybrid TAV-in-TAV With Low Valve Implantation and Bilateral Snorkel Stenting.
Yuta Kobayashi; Kiwamu Kamiya; Toshiyuki Nagai; Toshihisa Anzai
JACC. Cardiovascular interventions, 19, 18, 2532, 2533, 2026年09月28日, [国際誌]
英語, 研究論文(学術雑誌) - Post-TAVR Conduction Disturbances: Risk Stratification Using Consensus Algorithm and Membranous Septum Length.
Yuta Kobayashi; Yusuke Enta; Masaki Nakashima; Makoto Saigan; Natsuko Satomi; Yung Teng; Daishi Tazawa; Yoshiko Munehisa; Yukihiro Hayatsu; Norio Tada
JACC. Asia, 2026年07月02日, [国際誌]
英語, 研究論文(学術雑誌) - Association of Lipid Core Burden Index With Early Progression of Cardiac Allograft Vasculopathy in Patients After Heart Transplantation.
Kenta Otsuka; Sakae Takenaka; Toshiyuki Nagai; Takuma Sato; Takao Konishi; Atsushi Tada; Takeshi Hamaya; Yuki Mori; Akinori Takahashi; Sou Sasaki; Kento Tamano; Toshifumi Tamura; Sho Kazui; Yutaro Yasui; Yuta Kobayashi; Taro Temma; Kiwamu Kamiya; Satoru Wakasa; Toshihisa Anzai
Circulation journal : official journal of the Japanese Circulation Society, 90, 6, 752, 754, 2026年05月25日, [国内誌]
英語, 研究論文(学術雑誌), BACKGROUND: The association of the lipid-core burden index (LCBI), measured using near-infrared spectroscopy-intravascular ultrasound (NIRS-IVUS), with early progression of cardiac allograft vasculopathy remains unclear. METHODS AND RESULTS: We prospectively examined 12 consecutive heart transplant recipients who underwent NIRS-IVUS and IVUS. Patients were stratified according to the median maximum LCBI in a 4-mm segment (maxLCBI4 mm) of 223 at 1 month. The magnitude of maximal intimal thickness (MIT) progression was greater in the higher maxLCBI4 mmgroup. CONCLUSIONS: Patients with a higher maxLCBI4 mmat baseline exhibited greater MIT progression during the first post-transplant year. - The Verification of Co-Axiality of the Three Self-Expanding Transcatheter Aortic Valve Systems According to the Difference in Shaft Spine.
Yun Teng; Yusuke Enta; Makoto Saigan; Natsuko Satomi; Yuta Kobayashi; Masaki Nakashima; Momo Kosuga; Manabu Maeda; Yusuke Toki; Yoshiko Munehisa; Masaki Miyasaka; Masataka Taguri; Shigeru Toyoda; Norio Tada
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 107, 5, 1537, 1546, 2026年04月, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Accurate bioprosthesis implantation depth during transcatheter aortic valve replacement (TAVR) is crucial for optimal outcomes. Self-expanding valves (SEVs) have evolved delivery catheter designs, from a double spine shaft in Evolut PRO+ (PRO + ) to single spine in Evolut FX (FX) and non-spine in Navitor, to improve access deliverability. AIMS: To investigate the influence of different spine structures on valve implantation. METHODS: Retrospectively, we investigated 95 severe aortic stenosis patients who underwent transfemoral TAVR using SEVs (PRO + : 41, FX: 21, and Navitor: 33 patients) from January 2021 to July 2023. The implantation depth difference (IDD) between Left Coronary Cusp (LCC) and Non-Coronary Cusp (NCC) was measured angiographically at the point of no recapture, defined as subtracting NCC implantation depth from LCC. Positive IDD indicates deeper LCC than NCC, also shown as "vertical axis." Whereas negative IDD indicates shallower LCC than NCC, demonstrated as "horizontal axis." RESULTS: IDD at the point of no recapture showed significant difference among three groups (PRO + : 2.42 [0.81-3.42], FX: 1.01 [0.29-1.77], Navitor: -2.16[-2.74- (-1.14)] mm, p < 0.001, PRO + > FX/Navitor, FX > Navitor). PRO+ had a positive IDD, indicating deeper LCC implantation. Navitor had a negative IDD, demonstrating shallower implantation on LCC, and FX showed co-axial implantation. CONCLUSION: PRO+ with double spines showed vertical axis, Navitor with non-spine showed horizontal axis, whereas FX demonstrated co-axiality at the point of no recapture. This knowledge may help refine the manipulation of procedural implantation based on the shaft rigidity in each device to gain co-axiality. - Prognostic value of 18F-fluorodeoxyglucose positron emission tomography one month after initiation of prednisolone therapy in patients with cardiac sarcoidosis.
Toshifumi Tamura; Sakae Takenaka; Toshiyuki Nagai; Satonori Tsuneta; Takeshi Hamaya; Kenji Hirata; Yoshiya Kato; Hirokazu Komoriyama; Yuta Kobayashi; Atsushi Tada; Sho Kazui; Yutaro Yasui; Akinori Takahashi; Kiwamu Kamiya; Taro Temma; Takahiro Sato; Ichizo Tsujino; Kohsuke Kudo; Satoshi Konno; Toshihisa Anzai
International journal of cardiology, 448, 134181, 134181, 2026年04月01日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Current guidelines for cardiac sarcoidosis (CS) recommend maintaining the initial maximal dose of prednisolone (PSL) for one month after initiation; however, the prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) performed at this time point remains unclear. We sought to investigate whether FDG-PET performed at one month after the initiation of PSL is associated with adverse events in patients with CS. METHODS: We examined 109 consecutive CS patients who underwent FDG-PET at diagnosis and one month after initiating PSL between January 2010 and January 2025 in a university hospital. The change in maximum standardized uptake value (SUVmax) from baseline to one month was calculated. Responder was defined as those with an SUVmax reduction ≥25%, while non-responder had a reduction <25% or any increase. The primary outcome was a composite of aborted sudden cardiac death, sustained ventricular tachycardia, hospitalization of worsening heart failure, and all-cause death. RESULTS: Of the 109 patients, 83 were classified as responder and 26 as non-responder. Over a median follow-up of 4.9 years (interquartile range, 2.3-8.2), the primary outcome occurred in 37 patients. Non-responder had a significantly higher risk of the primary outcome, and this association persisted after sequential adjustment for established prognostic covariates. CONCLUSIONS: An inadequate reduction in SUVmax on FDG-PET performed one month after PSL initiation was independently associated with adverse clinical events in patients with CS. These findings suggest that non-responder represents a clinical challenge and even very early follow-up FDG-PET may provide prognostic insights. - Suitability for Transcarotid Transcatheter Aortic Valve Replacement in the Japanese Population.
Masaki Nakashima; Natsuko Satomi; Daishi Tazawa; Momo Kosuga; Manabu Maeda; Yun Teng; Yuta Kobayashi; Makoto Saigan; Yusuke Toki; Yusuke Enta; Masaki Miyasaka; Yoshiko Munehisa; Akihiro Yamamoto; Norio Tada
JACC. Asia, 6, 3, 345, 357, 2026年03月, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Transcarotid (TC) transcatheter aortic valve replacement (TAVR) has shown favorable outcomes in selected Western populations; however, data on its suitability in patients undergoing TAVR remain scarce. OBJECTIVES: The purpose of this study was to investigate the anatomical characteristics of the common carotid artery (CCA) and the suitability of Japanese patients for TC-TAVR. METHODS: This single-center retrospective study included consecutive patients who underwent TAVR between April 2023 and March 2024. Patients were categorized into a tough-transfemoral (TF) group, who may require an alternative approach, and a viable-TF group. TC-TAVR suitability was determined based on the CCA diameter, exposure site calcification, atherosclerotic plaque, and contralateral carotid artery stenosis. RESULTS: Among 336 patients, the right CCA was larger than the left CCA (6.6 ± 1.0 mm vs 6.4 ± 0.9 mm; P < 0.001) but exhibited greater tortuosity (44 of 336 [13.1%; 95% CI: 9.9%-17.1%] vs 9 of 336 [2.7%; 95% CI: 1.4%-5.0%]; P < 0.001). The tough-TF group had a higher incidence of major vascular complications (12 of 117 [10.3%; 95% CI: 6.0%-17.1%]) compared with the viable-TF group (3 of 219 [1.4%; 95% CI: 0.5%-3.9%]; P < 0.001). Overall suitability for TC-TAVR was high (306 of 336 [91.1%; 95% CI: 87.5%-93.7%]); however, it was significantly lower in the tough-TF group than in the viable-TF group (101 of 117 [86.3%; 95% CI: 78.9%-91.4%] vs 205 of 219 [93.6%; 95% CI: 89.6%-96.2%]; P = 0.042). Multivariate regression analysis identified peripheral artery disease as a negative predictor of suitability (OR: 0.42; 95% CI: 0.19-0.99; P = 0.039). CONCLUSIONS: Although TC-TAVR suitability was compromised in the tough-TF group, 86% remained suitable, suggesting that TC-TAVR may serve as a promising approach in the Japanese population. - Prognostic value of preprocedural pulmonary artery to ascending aorta ratio on non-contrast computed tomography in patients undergoing mitral transcatheter edge-to-edge repair.
Hiroki Uehara; Toshiyuki Nagai; So Sasaki; Kento Tamano; Toshifumi Tamura; Akinori Takahashi; Takeshi Hamaya; Yuki Mori; Yutaro Yasui; Sakae Takenaka; Satonori Tsuneta; Suguru Ishizaka; Yuta Kobayashi; Atsushi Tada; Taro Temma; Kiwamu Kamiya; Toshihisa Anzai
Heart and vessels, 2026年01月21日, [国内誌]
英語, 研究論文(学術雑誌) - Step-by-step bailout for MitraClip lock line stuck due to a knot.
Yuta Kobayashi; Yusuke Enta; Yoshiko Munehisa; Norio Tada
European heart journal. Case reports, 9, 11, ytaf510, 2025年11月, [国際誌]
英語, 研究論文(学術雑誌) - Incidence, Predictors, and Prognostic Impact of Left Ventricular Outflow Tract Obstruction Following Transcatheter Aortic Valve Replacement.
Yuta Kobayashi; Yusuke Enta; Masaki Nakashima; Makoto Saigan; Natsuko Satomi; Yung Teng; Daishi Tazawa; Yoshiko Munehisa; Masataka Taguri; Masaki Hata; Norio Tada
CJC open, 7, 9, 1236, 1243, 2025年09月, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Dynamic left ventricular outflow tract obstruction (LVOTO) following transcatheter aortic valve replacement (TAVR) is a potential complication that can cause severe hemodynamic instability. However, limited evidence is available regarding the incidence and predictors of LVOTO post-TAVR. This study aimed to clarify the incidence and identify the predictors of LVOTO following TAVR and to investigate whether LVOTO is associated with clinical outcomes. METHODS: This retrospective, single-centre study analyzed 2068 consecutive patients with aortic stenosis who underwent TAVR between January 2014 and December 2023. Transthoracic echocardiography was performed both before and after TAVR. LVOTO was defined as a peak pressure gradient exceeding 30 mm Hg. RESULTS: LVOTO occurred in 25 of 1963 patients (1.3%), with 6 patients developing acute hemodynamic compromise immediately after TAVR. Least absolute shrinkage and selection operator-penalized regression analysis identified the left ventricular outflow tract dimension (LVOTD), interventricular septum (IVS) thickness, transvalvular velocity, LVOT maximum velocity (Vmax), and aortic annulus-to-LVOT area ratio (A/L ratio) as independent predictors of LVOTO following TAVR. Kaplan-Meier analysis revealed no association between LVOTO following TAVR and all-cause mortality or rehospitalization for heart failure. CONCLUSIONS: The incidence of LVOTO after TAVR was 1.27%. Predictors of LVOTO were the IVS thickness, transvalvular velocity, LVOTD, LVOT Vmax, and A/L ratio. Notably, LVOTO following TAVR was not associated with the composite outcome of all-cause mortality or heart failure hospitalization. - Transcatheter Edge-to-Edge Mitral Valve Repair Using PASCAL System for a Patient With Medial Commissure Flail.
Yusuke Enta; Yoshiko Munehisa; Daishi Tazawa; Yun Teng; Natsuko Satomi; Yuta Kobayashi; Makoto Saigan; Masaki Nakashima; Masaki Miyasaka; Norio Tada
JACC. Case reports, 30, 19, 104051, 104051, 2025年07月16日, [国際誌]
英語, 研究論文(学術雑誌), OBJECTIVES: The aim of this report is to describe transcatheter edge-to-edge mitral valve repair using the PASCAL device in patients with medial commissure (MC) flail-induced primary mitral regurgitation. KEY STEPS: Perform a transseptal puncture above the MC. Insert the guide sheath (GS) into the left atrium (LA), guide the steerable catheter (SC) into the GS, and direct it toward the mitral valve. Withdraw the GS to the right atrium while maintaining the SC in the LA to approach the MC. Adjust the anterior-posterior trajectory using the GS flex knob. After leaflet grasping and PASCAL deployment, readvance the GS over the SC into the LA. POTENTIAL PITFALLS: Without a GS backup, the SC may become parallel to the aorta, hindering anterior leaflet visualization and complicating grasping. TAKE-HOME MESSAGES: The PASCAL device can be deployed safely even if the GS is withdrawn to the right atrium. Performing a transseptal puncture directly above the MC is essential to guide the SC when retracted. - Transcatheter Aortic Valve Replacement for Structural Valve Deterioration After Aortic Valve Neocuspidization.
Natsuko Satomi; Masaki Miyasaka; Yusuke Enta; Yoshiko Munehisa; Yusuke Toki; Masaki Nakashima; Makoto Saigan; Yuta Kobayashi; Yun Teng; Manabu Maeda; Momo Kosuga; Kazuo Abe; Masataka Taguri; Yukihiro Hayatsu; Masaki Hata; Norio Tada
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 106, 1, 610, 620, 2025年07月, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Evidence on structural valve deterioration (SVD) after aortic valve neocuspidization (AVNeo) remains limited. While transcatheter aortic valve replacement (TAVR) offers a less invasive option, its feasibility is unclear. This study aimed to characterize SVD patients post-AVNeo and to assess TAVR feasibility. METHODS: This retrospective study included 11 patients who underwent TAVR for SVD after AVNeo in Sendai Kousei Hospital between June 2017 and August 2024. Four patients with aortic stenosis (AS) and seven with aortic regurgitation (AR) due to SVD were included. RESULTS: AS-SVD group showed shorter time interval from AVNeo to TAVR (50.5 [28.3-98.3] vs. 107.0 [97.0-131.0] months, p = 0.04) and smaller aortic annulus area (316.5 [259.8-375.0] vs. 538.0 [440.0-582.0] mm2, p = 0.005) than AR-SVD group. In TAVR, technical success was achieved in 91% of cases. Although coronary obstruction is a concern due to the long leaflet, no case occurred. Misidentification of the basal ring plane caused by the slack cusp resulted in second valve implantation (one case) and new conduction disturbance (two cases) due to deep implantation, and aortic contained rupture (one case) for oversized valve selection. CONCLUSIONS: Rapid AS-SVD progression and AR-SVD occurring later than previously reported were observed, highlighting the need for further studies on AVNeo durability. TAVR after AVNeo was feasible. Special precautions for coronary obstruction may be unnecessary. Careful hinge point placement at the boundary between pericardial cusps and the annulus was a key to CT-based basal ring determination in patients after AVNeo. - Feasibility of guiding catheter exchange using extension wire in percutaneous coronary intervention after transcatheter aortic valve replacement.
Makoto Saigan; Masaki Miyasaka; Daishi Tazawa; Momo Kosuga; Manabu Maeda; Yun Teng; Natsuko Satomi; Yuta Kobayashi; Masaki Nakashima; Yusuke Enta; Yoshiko Munehisa; Yukihiro Hayatsu; Norio Tada
Cardiovascular intervention and therapeutics, 2025年06月24日, [国内誌]
英語, 研究論文(学術雑誌), Percutaneous coronary intervention (PCI) after transcatheter aortic valve replacement (TAVR) is technically challenging because of the presence of the transcatheter heart valve (THV), which complicates coronary artery engagement. Owing to their flexibility, diagnostic catheters (DCs) facilitate coronary access, but require subsequent exchange to guiding catheters (GCs) for PCI. The feasibility of using an extension wire (EW) to facilitate DC-to-GC exchange in this context remains unexplored. A retrospective analysis was conducted at our institution, examining 11 PCI cases performed after TAVR between January 6, 2020, and June 1, 2024, in which an EW was employed to transition from a DC to a GC. Clinical, angiographic, and procedural data were reviewed. Procedural success was defined as a successful DC-to-GC exchange and completion of PCI. DC-to-GC exchange using an EW was successfully achieved in all 11 cases (100%). Revascularization was achieved in 10/11 cases (91%). The lesions were uniformly classified as American College of Cardiology/American Heart Association Type B2/C. The GCs included Judkins-type in 7/11 cases (64%) and backup-type in 4/11 cases (36%). The THV types included SAPIEN in 6/11 cases (55%), Evolut in 3/11 cases (27%), and Navitor in 2/11 cases (18%). A 6Fr GC was utilized in 10/11 cases (91%), and rotational atherectomy was performed in 1/11 cases (9%). The use of an EW to facilitate the transition from DC to GC in PCI after TAVR resulted in high procedural success, providing a feasible approach for addressing complex lesions and optimizing procedural outcomes. - Impact of right ventricular reserve function during exercise on aortic valve opening in patients with left ventricular assist device.
Sakae Takenaka; Takuma Sato; Toshiyuki Nagai; Atsushi Tada; Yuta Kobayashi; Sho Kazui; Yutaro Yasui; Takeshi Hamaya; Yuki Mori; Akinori Takahashi; Suguru Ishizaka; Takao Konishi; Taro Temma; Kiwamu Kamiya; Tomonori Ooka; Satoru Wakasa; Toshihisa Anzai
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2025年05月31日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Although aortic valve (AV) opening during exercise has fewer adverse events in patients with a left ventricular (LV) assist device (LVAD), factors associated with it remain unclear. We hypothesized that right ventricular (RV) reserve function is associated with the AV opening status. This study aimed to explore the hemodynamic parameters observed at rest and during maximal exercise and investigate the association between the RV reserve function and AV opening status in patients with an LVAD. METHODS: We prospectively examined 25 consecutive patients with an LVAD who underwent invasive exercise right heart catheterization with simultaneous echocardiography in the supine position. The AV opening status was assessed at rest and during exercise. The change in RV stroke work index (RVSWI) from rest to peak exercise (ΔRVSWI) was calculated to assess the RV reserve function. Patients were divided into three groups according to AV opening: AV opening both at rest and during exercise (n = 7), AV opening during exercise only (n = 8), and closed AV (n = 10). RESULTS: Patients with a closed AV had significantly lower ΔRVSWI and ΔRV dP/dt max than those with AV opening both at rest and during exercise and AV opening during exercise only, whereas changes in pulmonary artery wedge pressure and pulmonary vascular resistance were comparable across the groups. In a multivariable logistic regression analysis, ΔRVSWI was independently associated with AV opening even after adjustment for the change in LV ejection fraction from rest to peak exercise. During a median follow-up period of 743 (interquartile range, 483-1037) days, the incidence of adverse events was higher in patients in the closed AV group than in those in the AV opening groups (p = 0.002). CONCLUSIONS: RV reserve function is associated with AV opening status in patients with an LVAD. CLINICAL TRIAL REGISTRATION: URL: https://www.umin.ac.jp/ctr/index.htm. Unique Identifier: UMIN000039001. - Bailout Double-Sheath Technique to Dilate the Interatrial Septum for Accidentally Pulled-Back Watchman Access Sheath.
Masaki Nakashima; Momo Kosuga; Yuta Kobayashi; Yoshiko Munehisa; Norio Tada
JACC. Case reports, 30, 8, 103208, 103208, 2025年04月16日, [国際誌]
英語, 研究論文(学術雑誌), During percutaneous left atrial appendage closure using the Watchman device, the access sheath usually remains in the left atrium. We experienced a case in which we could not recapture the device, because the access sheath was accidentally pulled back to the right atrium. Because bailout from the access sheath was unsuccessful, balloon dilation of the interatrial septum was performed using a double-sheath technique via the contralateral femoral vein. Interatrial septum balloon dilation facilitates device traversal into the left atrium. Likewise, balloon dilation using a double-sheath technique is a safe and effective approach for managing such situations. - Unavoidable Iatrogenic Mitral Stenosis Following Transcatheter Edge-to-Edge Mitral Valve Repair With Current Devices.
Yusuke Enta; Makoto Saigan; Yoshiko Munehisa; Shunichi Ichikawa; Keita Yoshiyama; Momo Kosuga; Manabu Maeda; Yun Teng; Natsuko Satomi; Yuta Kobayashi; Masaki Nakashima; Yusuke Toki; Masaki Miyasaka; Yukihiro Hayatsu; Norio Tada
JACC. Cardiovascular interventions, 18, 3, 395, 397, 2025年02月10日, [国際誌]
英語, 研究論文(学術雑誌) - Balloon-assisted bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction with en face view for patients exhibiting severe calcified leaflet: a case report.
Yuta Kobayashi; Yusuke Enta; Masaki Nakashima; Norio Tada
European heart journal. Case reports, 8, 12, ytae643, 2024年12月, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Balloon-assisted bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BA-BASILICA) enables valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) in patients at risk of coronary artery obstruction. However, its efficacy in patients with severely calcified leaflets remains unclear. CASE SUMMARY: We report a 78-year-old woman with a deteriorated 21 mm Carpentier-Edwards PERIMOUNT Magna valve. Computed tomography showed severe calcification in the left coronary leaflet, extending above the left coronary artery (LCA) ostium, with a virtual transcatheter heart valve to coronary ostium distance of 3.7 mm, indicating a high risk of coronary obstruction after ViV-TAVI. We performed ViV-TAVI using the BA-BASILICA because of the patient's high surgical risks. Traversal of the calcified leaflet was successfully achieved using both en face and side views to visualize the traversal system's position in an area without calcification and in front of the LCA. After traversal, the leaflet was dilated with a balloon and accidentally split into two. A 20 mm SAPIEN 3 Ultra RESILIA valve was deployed. Despite initial procedural success, severe LCA stenosis developed due to leaflet compression. This was resolved by orthotopic stenting using an en face view to identify cells not covered by the bioprosthetic leaflet generated by BA-BASILICA. DISCUSSION: To our knowledge, this is the first report of ViV-TAVI using the BA-BASILICA with an en face view of severely calcified leaflets. This case suggests that BA-BASILICA with an en face view could be effective for patients at high risk of coronary obstruction with severely calcified leaflets. - Multimodal Assessment of Immunosuppressive Therapy in a Patient With Chronic Active Myocarditis 3 Months Following COVID-19 Infection.
Yuta Kobayashi; Takeshi Hamaya; Toshiyuki Nagai; Yuki Mori; Takuma Sato; Satonori Tsuneta; Kento Wakabayashi; Kohsuke Kudo; Yoshihiro Matsuno; Toshihisa Anzai
CJC open, 6, 6, 826, 829, 2024年06月, [国際誌]
英語, 研究論文(学術雑誌) - Chronic Active Myocarditis After Transapical Transcatheter Aortic Valve Implantation.
Yuta Kobayashi; Toshiyuki Nagai; Kiwamu Kamiya; Satonori Tsuneta; Yasushige Shingu; Kento Wakabayashi; Kohsuke Kudo; Yoshihiro Matsuno; Satoru Wakasa; Toshihisa Anzai
Circulation journal : official journal of the Japanese Circulation Society, 88, 6, 1008, 1008, 2024年05月24日, [国内誌]
英語, 研究論文(学術雑誌) - Prognostic Value of Combined Assessments of Late Gadolinium Enhancement and Fluorodeoxyglucose Uptake in Cardiac Sarcoidosis.
Sho Kazui; Sakae Takenaka; Toshiyuki Nagai; Satonori Tsuneta; Kenji Hirata; Yoshiya Kato; Hirokazu Komoriyama; Yuta Kobayashi; Akinori Takahashi; Kiwamu Kamiya; Taro Temma; Takuma Sato; Atsushi Tada; Yutaro Yasui; Michikazu Nakai; Takahiro Sato; Ichizo Tsujino; Kohsuke Kudo; Satoshi Konno; Toshihisa Anzai
JACC. Cardiovascular imaging, 2024年03月11日, [国際誌]
英語 - Implications of the En Face View of Transcatheter Heart Valves for Coronary Access Post-TAVR.
Masaki Nakashima; Masaki Miyasaka; Natsuko Satomi; Yuta Kobayashi; Suguru Hirose; Makoto Saigan; Yusuke Enta; Tsuyoshi Ishizone; Kazuyuki Nakamura; Masaki Hata; Norio Tada
JACC. Cardiovascular interventions, 16, 24, 3049, 3051, 2023年12月25日, [国際誌]
英語 - Exercise Capacity and Clinical Outcomes in Chronic Heart Failure Patients with Mild Tricuspid Regurgitation.
Kosuke Nakamura; Suguru Ishizaka; Kazunori Omote; Yutaro Yasui; Yoshifumi Mizuguchi; Sakae Takenaka; Yui Shimono; Ko Motoi; Hiroyuki Aoyagi; Yoji Tamaki; Sho Kazui; Yuki Takahashi; Kohei Saiin; Seiichiro Naito; Atsushi Tada; Yuta Kobayashi; Takuma Sato; Kiwamu Kamiya; Toshiyuki Nagai; Toshihisa Anzai
Journal of clinical medicine, 12, 23, 2023年12月01日, [国際誌]
英語, 研究論文(学術雑誌), AIM: The present study aimed to investigate the impact of mild tricuspid regurgitation (TR) on the exercise capacity or clinical outcomes in patients with chronic heart failure (CHF). METHODS AND RESULTS: The study enrolled 511 patients with CHF who underwent cardiopulmonary exercise testing (CPET) between 2013 and 2018. The primary outcome was a composite of heart failure hospitalization and death. Patients with mild TR (n = 324) or significant TR (moderate or greater; n = 60) displayed worse NHYA class and reduced exercise capacity on CPET than those with non-TR (n = 127), but these were more severely impaired in patients with significant TR. A total of 90 patients experienced events over a median follow-up period of 3.3 (interquartile range 0.8-5.5) years. Patients with significant TR displayed a higher risk of events, while patients with mild TR had a 3.0-fold higher risk of events than patients with non-TR (hazard ratio (HR) 3.01; 95% confidence interval (CI), 1.50-6.07). Multivariate Cox regression analysis showed that, compared with non-TR, mild TR was associated with increased adverse events, even after adjustment for co-variates (HR 2.97; 95% CI, 1.35-6.55). CONCLUSIONS: TR severity was associated with worse symptoms, reduced exercise capacity, and poor clinical outcomes. Even patients with mild TR had worse clinical characteristics than those with non-TR. - Differences in blood flow dynamics between balloon- and self-expandable valves in patients with aortic stenosis undergoing transcatheter aortic valve replacement.
Yuki Takahashi; Kiwamu Kamiya; Toshiyuki Nagai; Satonori Tsuneta; Noriko Oyama-Manabe; Takeshi Hamaya; Sho Kazui; Yutaro Yasui; Kohei Saiin; Seiichiro Naito; Yoshifumi Mizuguchi; Sakae Takenaka; Atsushi Tada; Suguru Ishizaka; Yuta Kobayashi; Kazunori Omote; Takuma Sato; Yasushige Shingu; Kohsuke Kudo; Satoru Wakasa; Toshihisa Anzai
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 25, 1, 60, 60, 2023年10月26日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: The differences in pre- and early post-procedural blood flow dynamics between the two major types of bioprosthetic valves, the balloon-expandable valve (BEV) and self-expandable valve (SEV), in patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR), have not been investigated. We aimed to investigate the differences in blood flow dynamics between the BEV and SEV using four-dimensional flow cardiovascular magnetic resonance (4D flow CMR). METHODS: We prospectively examined 98 consecutive patients with severe AS who underwent TAVR between May 2018 and November 2021 (58 BEV and 40 SEV) after excluding those without CMR because of a contraindication, inadequate imaging from the analyses, or patients' refusal. CMR was performed in all participants before (median interval, 22 [interquartile range (IQR) 4-39] days) and after (median interval, 6 [IQR 3-6] days) TAVR. We compared the changes in blood flow patterns, wall shear stress (WSS), and energy loss (EL) in the ascending aorta (AAo) between the BEV and SEV using 4D flow CMR. RESULTS: The absolute reductions in helical flow and flow eccentricity were significantly higher in the SEV group compared in the BEV group after TAVR (BEV: - 0.22 ± 0.86 vs. SEV: - 0.85 ± 0.80, P < 0.001 and BEV: - 0.11 ± 0.79 vs. SEV: - 0.50 ± 0.88, P = 0.037, respectively); there were no significant differences in vortical flow between the groups. The absolute reduction of average WSS was significantly higher in the SEV group compared to the BEV group after TAVR (BEV: - 0.6 [- 2.1 to 0.5] Pa vs. SEV: - 1.8 [- 3.5 to - 0.8] Pa, P = 0.006). The systolic EL in the AAo significantly decreased after TAVR in both the groups, while the absolute reduction was comparable between the groups. CONCLUSIONS: Helical flow, flow eccentricity, and average WSS in the AAo were significantly decreased after SEV implantation compared to BEV implantation, providing functional insights for valve selection in patients with AS undergoing TAVR. Our findings offer valuable insights into blood flow dynamics, aiding in the selection of valves for patients with AS undergoing TAVR. Further larger-scale studies are warranted to confirm the prognostic significance of hemodynamic changes in these patients. - 心臓サルコイドーシス患者の免疫抑制療法開始後における心筋トロポニン値経時的評価の予後的意義
數井 翔; 竹中 秀; 永井 利幸; 加藤 喜哉; 小森山 弘和; 小林 雄太; 高橋 昌寛; 神谷 究; 佐藤 琢真; 多田 篤司; 安井 悠太郎; 中井 陸運; 佐藤 隆博; 辻野 一三; 今野 哲; 安斉 俊久
日本サルコイドーシス/肉芽腫性疾患学会雑誌, 43, サプリメント号, 64, 64, 日本サルコイドーシス, 2023年10月
日本語 - 心臓サルコイドーシス患者におけるガドリニウム遅延造影心臓MRIとFDG-PETを用いた複合的画像評価の予後的意義
數井 翔; 竹中 秀; 永井 利幸; 常田 慧徳; 加藤 喜哉; 小森山 弘和; 小林 雄太; 高橋 昌寛; 神谷 究; 天満 太郎; 佐藤 琢真; 多田 篤司; 安井 悠太郎; 中井 陸運; 佐藤 隆博; 辻野 一三; 工藤 與亮; 今野 哲; 安斉 俊久
日本サルコイドーシス/肉芽腫性疾患学会雑誌, 43, サプリメント号, 65, 65, 日本サルコイドーシス, 2023年10月
日本語 - 心臓サルコイドーシス患者の免疫抑制療法開始後における心筋トロポニン値経時的評価の予後的意義
數井 翔; 竹中 秀; 永井 利幸; 加藤 喜哉; 小森山 弘和; 小林 雄太; 高橋 昌寛; 神谷 究; 佐藤 琢真; 多田 篤司; 安井 悠太郎; 中井 陸運; 佐藤 隆博; 辻野 一三; 今野 哲; 安斉 俊久
日本サルコイドーシス/肉芽腫性疾患学会雑誌, 43, サプリメント号, 64, 64, 日本サルコイドーシス, 2023年10月
日本語 - 心臓サルコイドーシス患者におけるガドリニウム遅延造影心臓MRIとFDG-PETを用いた複合的画像評価の予後的意義
數井 翔; 竹中 秀; 永井 利幸; 常田 慧徳; 加藤 喜哉; 小森山 弘和; 小林 雄太; 高橋 昌寛; 神谷 究; 天満 太郎; 佐藤 琢真; 多田 篤司; 安井 悠太郎; 中井 陸運; 佐藤 隆博; 辻野 一三; 工藤 與亮; 今野 哲; 安斉 俊久
日本サルコイドーシス/肉芽腫性疾患学会雑誌, 43, サプリメント号, 65, 65, 日本サルコイドーシス, 2023年10月
日本語 - 房室結節アブレーション、CRT-D植え込み術、経皮的僧帽弁接合不全修復術のHybrid治療でドブタミンを離脱し得た重症心不全の一例
濱谷 孟志; 小林 雄太; 森 勇喜; 佐藤 琢真; 天満 太郎; 神谷 究; 永井 利幸; 安斉 俊久
日本心臓病学会学術集会抄録, 71回, C, 2, (一社)日本心臓病学会, 2023年09月
日本語 - Association of longitudinal cardiac troponin trajectory with adverse events in patients with cardiac sarcoidosis.
Sho Kazui; Sakae Takenaka; Toshiyuki Nagai; Yoshiya Kato; Hirokazu Komoriyama; Yuta Kobayashi; Akinori Takahashi; Kiwamu Kamiya; Takuma Sato; Atsushi Tada; Yutaro Yasui; Michikazu Nakai; Takahiro Sato; Ichizo Tsujino; Satoshi Konno; Toshihisa Anzai
International journal of cardiology, 389, 131268, 131268, 2023年08月15日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Although high-sensitivity cardiac troponins may be sensitive and easily repeatable markers of disease activity in patients with cardiac sarcoidosis (CS), the association between longitudinal cardiac troponin trajectory and adverse events remains unclear. This study aimed to clarify whether longitudinal cardiac troponin levels were associated with adverse events in patients with CS. METHODS: We examined 63 consecutive CS-initiated prednisolone (PSL) patients with available longitudinal high-sensitivity cardiac troponin T (cTnT) data between December 2013 and March 2023. The area under the cTnT trajectory, which reflected cumulative cTnT release, was calculated to assess the association between longitudinal cTnT levels and adverse events. Patients were divided into two groups according to the median area under the cTnT trajectory per month. The primary outcome was a composite of sustained ventricular tachycardia or fibrillation, worsening heart failure, and sudden cardiac death (SCD). RESULTS: In total, 463 cTnT measurements were collected over a median follow-up period of 30.4 (interquartile range [IQR] 15.6-34.2) months. The primary outcome was observed in 12 (19%) patients. A higher area under the cTnT trajectory was significantly associated with an increased incidence of the primary outcome (P = 0.027), while cTnT levels before and one month after initiation of PSL, and these changes were not related to adverse events (P = 0.179, 0.096, and 0.95, respectively). CONCLUSIONS: Longitudinal cTnT trajectory following PSL initiation was associated with adverse cardiac events in patients with CS, suggesting that longitudinal measurement of cTnT would be useful for the early identification of high-risk patients. - Prognostic Value of Liver Fibrotic Markers in Patients With Heart Failure.
Atsushi Tada; Toshiyuki Nagai; Yoshiya Kato; Noriko Oyama-Manabe; Satonori Tsuneta; Michikazu Nakai; Yutaro Yasui; Sho Kazui; Yuki Takahashi; Kohei Saiin; Seiichiro Naito; Sakae Takenaka; Yoshifumi Mizuguchi; Yuta Kobayashi; Suguru Ishizaka; Kazunori Omote; Takuma Sato; Takao Konishi; Kiwamu Kamiya; Kohsuke Kudo; Toshihisa Anzai
The American journal of cardiology, 200, 115, 123, 2023年06月10日, [国際誌]
英語, 研究論文(学術雑誌), Several liver fibrotic markers are associated with prognosis in patients with heart failure (HF). However, the optimal markers for outcome prediction remain unclear. This study aimed to simultaneously investigate the prognostic value of liver fibrotic markers and the associations between these markers and clinical parameters in patients with HF without organic liver disease. We prospectively examined 211 consecutive patients with chronic HF between April 2018 and August 2021, excluding those with organic liver disease, using liver magnetic resonance imaging and ultrasound. A total of 7 representative liver fibrotic markers were measured in all patients. The primary outcome of interest was the composite of all-cause death and hospitalization for worsening HF. During a median follow-up period of 747 (interquartile range 465 to 1,042) days, the primary outcome occurred in 45 patients. Patients with higher hyaluronic acid and type III procollagen N-terminal peptide (P-III-P) levels showed a significantly higher incidence of the primary outcome than those without (p <0.001 and p = 0.005, respectively). The multivariable Cox regression analysis revealed that hyaluronic acid and P-III-P levels were independently associated with the risk of adverse events (hazard ratio 1.84, 95% confidence interval 1.18 to 2.87 and hazard ratio 2.89, 95% confidence interval 1.32 to 6.34, respectively) even after adjustment for a mortality prediction model, whereas the other 5 markers were not associated with the primary outcome. In conclusion, among the representative liver fibrotic markers, hyaluronic acid and P-III-P might be the optimal markers for outcome prediction in patients with HF. - Impact of right ventricular reserve on exercise capacity and quality of life in patients with left ventricular assist device.
Sakae Takenaka; Takuma Sato; Toshiyuki Nagai; Kazunori Omote; Yuta Kobayashi; Kiwamu Kamiya; Takao Konishi; Atsushi Tada; Yoshifumi Mizuguchi; Yuki Takahashi; Seiichiro Naito; Kohei Saiin; Suguru Ishizaka; Satoru Wakasa; Toshihisa Anzai
American journal of physiology. Heart and circulatory physiology, 324, 3, H355-H363, 2023年03月01日, [国際誌]
英語, 研究論文(学術雑誌), Although measuring right ventricular (RV) function during exercise is more informative than assessing it at rest, the relationship between RV reserve function, exercise capacity, and health-related quality of life (HRQoL) in patients with left ventricular assist devices (LVAD) remains unresolved. We aimed to investigate whether RV reserve assessed by the change in RV stroke work index (RVSWI) during exercise is correlated with exercise capacity and HRQoL in patients with LVAD. We prospectively assessed 24 consecutive patients with LVAD who underwent invasive right heart catheterization in the supine position. Exercise capacity and HRQoL were assessed using the 6-min walk distance (6 MWD) and peak oxygen consumption (V̇o2) in cardiopulmonary exercise testing, and the EuroQol visual analog scale (EQ-VAS), respectively. The patients were divided into two groups according to the median ΔRVSWI (change from rest to peak exercise). Patients with lower ΔRVSWI had significantly lower changes in cardiac index and absolute value of RV dP/dt than those with higher ΔRVSWI. The ΔRVSWI was positively correlated with 6 MWD (r = 0.59, P = 0.003) and peak V̇o2 (r = 0.56, P = 0.006). In addition, ΔRVSWI was positively correlated with the EQ-VAS (r = 0.44, P = 0.030). In contrast, there was no significant correlation between RVSWI at rest and 6 MWD (r = -0.34, P = 0.88), peak V̇o2 (r = 0.074, P = 0.74), or EQ-VAS (r = 0.127, P = 0.56). Our findings suggest that the assessment of RV reserve function is useful for risk stratification in patients with LVAD.NEW & NOTEWORTHY The change in right ventricular stroke work index (RVSWI) during exercise, not RVSWI at rest, was associated with exercise capacity and HRQoL. Our findings suggest that the assessment of change in RVSWI during exercise as a surrogate of RV reserve function may aid in risk stratification of patients with LVAD. - Prognostic Significance of Peak Workload-to-Weight Ratio by Cardiopulmonary Exercise Testing in Chronic Heart Failure.
Yutaro Yasui; Kosuke Nakamura; Kazunori Omote; Suguru Ishizaka; Sakae Takenaka; Yoshifumi Mizuguchi; Yui Shimono; Sho Kazui; Yuki Takahashi; Kohei Saiin; Seiichiro Naito; Atsushi Tada; Yuta Kobayashi; Takuma Sato; Kiwamu Kamiya; Toshiyuki Nagai; Toshihisa Anzai
The American journal of cardiology, 193, 37, 43, 2023年03月01日, [国際誌]
英語, 研究論文(学術雑誌), The prognostic impact of peak workload-to-weight ratio (PWR) during cardiopulmonary exercise testing (CPET) and its determinants in patients with chronic heart failure (CHF) are not well understood. Consecutive 514 patients with CHF referred for CPET at the Hokkaido University Hospital between 2013 and 2018 were identified. The primary outcome was a composite of hospitalization because of worsening heart failure and death. PWR was calculated as peak workload normalized to body weight (W/kg) by CPET. Patients with low PWR (cut-off median 1.38 [W/kg], n = 257) were older and more anemic than those with high PWR (n = 257). In CPET, patients with low PWR displayed reduced peak oxygen consumption and impaired ventilatory efficiency compared with those with high PWR, whereas the peak respiratory exchange ratio was not significantly different between the 2 groups. There were 89 patients with events over a median follow-up period of 3.3 (interquartile range 0.8 to 5.5) years. The incidence of composite events was significantly higher in patients with low PWR than in those with high PWR (log-rank p <0.0001). In the multivariable Cox regression, lower PWR was associated with adverse events (hazard ratio 0.31, 95% confidence interval 0.13 to 0.73, p = 0.008). Low hemoglobin concentration was strongly related to impaired PWR (β coefficient = 0.43, per 1 g/100 ml increased, p <0.0001). In conclusion, PWR was associated with worse clinical outcomes, where blood hemoglobin was strongly related to PWR. Further study is required to identify therapies targeting peak workload achievements in exercise stress tests to improve the outcome in patients with CHF. - Fragmented QRS on 12-lead electrocardiogram predicts long-term prognosis in patients with cardiac sarcoidosis.
Hikaru Hagiwara; Masaya Watanabe; Takahide Kadosaka; Takuya Koizumi; Yuta Kobayashi; Taro Koya; Motoki Nakao; Satonori Tsuneta; Yoshiya Kato; Hirokazu Komoriyama; Rui Kamada; Toshiyuki Nagai; Kohsuke Kudo; Toshihisa Anzai
Heart and vessels, 2023年01月13日, [国内誌]
英語, 研究論文(学術雑誌), Fragmented QRS (fQRS) on a 12-lead electrocardiogram is a known marker of fatal arrhythmias or cardiac adverse events in ischemic and non-ischemic cardiomyopathy patients. Nonetheless, the association between fQRS and clinical outcomes in patients with cardiac sarcoidosis (CS) remains unclear. Herein, we investigated whether fQRS is associated with long-term clinical outcomes in CS patients. A total of 78 patients who received immunosuppressive therapy (IST) for clinically diagnosed CS were retrospectively examined. Patients were classified into two groups according to the presence (n = 19) or absence (n = 59) of fQRS on electrocardiogram before IST. The primary outcome was the composite event of all-cause death, ventricular tachyarrhythmias (VTs), and hospitalization for heart failure. Results of late gadolinium enhancement on cardiac magnetic resonance imaging were also analyzed. During a median follow-up period of 3.7 years (interquartile range: 1.6-6.2 years), the primary outcome occurred more frequently in patients with fQRS than in those without (47% vs. 13%, log-rank p = 0.002). Multivariable Cox regression analyses showed that fQRS was an independent determinant of the primary outcome. The incidence of VTs, within 12 months of IST initiation, was comparable between the two groups; however, late-onset VTs, defined as those occurring ≥ 12 months after IST initiation, occurred more frequently in the fQRS group (21% vs. 2%, log-rank p = 0.002). The scar zone and scar border zone were greater in patients with fQRS than in those without it. In conclusion, our analysis suggests that fQRS is an independent predictor of adverse events, particularly late-onset VTs, in patients with CS. - Association of coronary plaque morphology with inflammatory biomarkers and target lesion revascularization in patients with chronic coronary syndrome: an optical coherence tomography study.
Kohei Saiin; Takao Konishi; Sho Kazui; Yutaro Yasui; Yuki Takahashi; Seiichiro Naito; Sakae Takenaka; Yoshifumi Mizuguchi; Atsushi Tada; Yuta Kobayashi; Yoshiya Kato; Kazunori Omote; Takuma Sato; Kiwamu Kamiya; Toshiyuki Nagai; Shinya Tanaka; Toshihisa Anzai
American journal of cardiovascular disease, 13, 5, 309, 319, 2023年, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: The characteristics of high-risk coronary atherosclerosis evaluated using optical coherence tomography (OCT) can have a prognostic role. Inflammatory biomarkers may be related to the severity of coronary artery disease. This study investigated the association of high-risk morphological features of coronary plaques on OCT with circulating levels of inflammatory biomarkers and target lesion revascularization (TLR). MATERIALS AND METHODS: We prospectively analyzed the data of 30 consecutive patients with chronic coronary syndrome who underwent percutaneous coronary intervention (PCI) using OCT. The levels of interleukin-6, tumor necrosis factor-alpha, high-sensitivity C-reactive protein, pentraxin 3, vascular endothelial growth factor, and monocyte chemoattractant protein-1 (MCP-1) were measured in plasma samples. Coronary plaque characteristics were scored quantitatively in the form of coronary plaque risk score (CPRS). The estimated high-risk plaque characteristics for TLR were plaque rupture, plaque erosion, calcified nodule, lipid-rich plaque, thin-cap fibroatheroma, cholesterol crystals, macrophage infiltration, microchannels, calcification angle >90°, and microcalcifications. Each high-risk feature carries 1 point. Patients were defined as having a low CPRS (CPRS ≤3) or a high CPRS (CPRS ≥4). RESULTS: The primary outcome was TLR. TLR occurred in 6 (20%) patients within 15 months of PCI. High CPRS on OCT was directly correlated with TLR (P=0.029). In logistic regression analysis, CPRS was associated with TLR (odds ratio, 10.0; 95% confidence interval, 1.34-74.5). Serum MCP-1 level was significantly correlated with the CPRS (P=0.020). CONCLUSIONS: In patients with chronic coronary syndrome, CPRS may be a surrogate predictor of TLR. Serum MCP-1 may aid in the detection of high-risk coronary atherosclerosis. - Liver stiffness assessed by magnetic resonance elastography predicts clinical outcomes in patients with heart failure and without chronic liver disease.
Atsushi Tada; Toshiyuki Nagai; Yoshiya Kato; Kazunori Omote; Noriko Oyama-Manabe; Satonori Tsuneta; Yusuke Kudo; Mutsumi Nishida; Michikazu Nakai; Yuki Takahashi; Kohei Saiin; Seiichiro Naito; Yuta Kobayashi; Sakae Takenaka; Yoshifumi Mizuguchi; Kiwamu Kamiya; Takao Konishi; Takuma Sato; Kohsuke Kudo; Toshihisa Anzai
European radiology, 33, 3, 2062, 2074, 2022年11月03日, [国際誌]
英語, 研究論文(学術雑誌), OBJECTIVES: Evaluation of liver stiffness (LS) by magnetic resonance elastography (MRE) is useful for estimating right atrial pressure (RAP) in patients with heart failure (HF). However, its prognostic implications are unclear. We sought to investigate whether LS measured by MRE (LS-MRE) could predict clinical outcomes in patients with HF. METHODS: We prospectively examined 207 consecutive HF patients between April 2018 and May 2021 after excluding those with organic liver disease. All patients underwent 3.0-T MRE. The primary outcome of interest was the composite of all-cause death and hospitalisation for HF. RESULTS: During a median follow-up period of 720 (interquartile range [IQR] 434-1013) days, the primary outcome occurred in 44 patients (21%), including 15 (7%) all-cause deaths and 29 (14%) hospitalisations for HF. The patients were divided into two groups according to median LS-MRE of 2.54 (IQR 2.34-2.82) kPa. Patients with higher LS-MRE showed a higher incidence of the primary outcome compared to those with lower LS-MRE (p < 0.001). Multivariable Cox regression analyses revealed that LS-MRE value was independently associated with the risk of adverse events (hazard ratio 2.49, 95% confidence interval 1.46-4.24). In multivariable linear regression, RAP showed a stronger correlation with LS-MRE (β coefficient = 0.31, p < 0.001) compared to markers related to liver fibrosis. CONCLUSIONS: In patients without chronic liver disease and presenting with HF, elevated LS-MRE was independently associated with worse clinical outcomes. Elevated LS-MRE may be useful for risk stratification in patients with HF and without chronic liver disease. KEY POINTS: • Magnetic resonance elastography (MRE) is an emerging non-invasive imaging technique for evaluating liver stiffness (LS) which can estimate right atrial pressure. • Elevated LS-MRE, which mainly reflects liver congestion, was independently associated with worse clinical outcomes in patients with heart failure. • The assessment of LS-MRE would be useful for stratifying the risk of adverse events in heart failure patients without chronic liver disease. - 日本人心臓サルコイドーシス患者におけるAHA/ACC/HRSガイドライン植込型除細動器適応の外的妥当性
竹中 秀; 小林 雄太; 永井 利幸; 加藤 喜哉; 小森山 弘和; 永野 伸卓; 神谷 究; 小西 崇夫; 佐藤 琢真; 表 和徳; 多田 篤司; 水口 賢史; 草野 研吾; 植田 初江; 安斉 俊久
日本サルコイドーシス/肉芽腫性疾患学会雑誌, 42, サプリメント号, 64, 64, 日本サルコイドーシス, 2022年10月
日本語 - 末期心不全患者の難治性不整脈に対するICD治療機能停止(deactivation)の検討を多職種で行った一例
甲谷 次郎; 佐藤 琢真; 立田 大志郎; 西野 広太郎; 小林 雄太; 成田 尚; 敦賀 健吉; 青陽 千果; 池田 陽子; 小島 尚子; 古山 勇気; 小野田 紘子; 加藤 美香; 永井 利幸; 安斉 俊久
日本心臓病学会学術集会抄録, 70回, C, 3, (一社)日本心臓病学会, 2022年09月
日本語 - COVID-19で入院加療中に冠攣縮性狭心症を併発した褐色細胞腫の一例
高橋 昌寛; 佐藤 琢真; 立田 大志郎; 甲谷 次郎; 西野 広太郎; 小林 雄太; 小西 崇夫; 永井 利幸; 安斉 俊久
日本心臓病学会学術集会抄録, 70回, C, 5, (一社)日本心臓病学会, 2022年09月
日本語 - MitraClip実施後にたこつぼ症候群を呈した1例
甲谷 次郎; 神谷 究; 立田 大志郎; 西野 広太郎; 高橋 勇樹; 斎院 康平; 内藤 正一郎; 竹中 秀; 多田 篤司; 水口 賢史; 石坂 傑; 小林 雄太; 佐藤 琢真; 永井 利幸; 安斉 俊久
日本心血管インターベンション治療学会抄録集, 30回, [YIA4, 2], (一社)日本心血管インターベンション治療学会, 2022年07月
英語 - 【循環器薬の使い方-使い分け,モニタリング,導入・中止のタイミング】心不全 RAS阻害薬からARNIまで
小林 雄太; 安斉 俊久
循環器ジャーナル, 70, 2, 218, 224, (株)医学書院, 2022年04月
日本語 - Long-term preservation of functional capacity and quality of life in advanced heart failure patients with bridge to transplant therapy: A report from Japanese nationwide multicenter registry.
Takuma Sato; Yuta Kobayashi; Toshiyuki Nagai; Takeshi Nakatani; Jon Kobashigawa; Yoshikatsu Saiki; Minoru Ono; Satoru Wakasa; Toshihisa Anzai
International journal of cardiology, 356, 66, 72, 2022年03月22日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Under the revised heart allocation system in the United States, bridge to transplant (BTT) patients with left ventricular assist device (LVAD) have a longer waitlist period, as they are now lowly prioritized. However, little is known regarding the long-term trajectory of functional capacity (FC) and health-related quality of life (HR-QOL) among BTT-LVAD patients. METHODS: We retrospectively analyzed 442 consecutive patients with BTT-LVAD between April 2013 and May 2019 from a Japanese nationwide registry. FC (New York Heart Association [NYHA] functional class, peak oxygen uptake [VO2], and 6-min walk test [6MWT]) and HR-QOL (European Quality of Life [EQ-5D index] and Visual Analogue Scale [EQ-VAS]) were assessed at baseline and for up to 60 months after LVAD implantation. RESULTS: During the follow-up period of 30 months (IQR 18-42 months), 100 (22.6%) patients underwent transplantation, 37 (8.3%) died, and 14 (3.1%) underwent explantation for recovery. Mean peak VO2, 6MWT distance, EQ-5D index, and EQ-VAS significantly improved 3 months after LVAD implantation (p = 0.0012, p = 0.0037, p < 0.001, p < 0.001, respectively). Furthermore, these improvements were sustained for up to 60 months following LVAD implantation. Major adverse events including device failure, infection, stroke, and bleeding, which occurred within the first 3 months after LVAD implantation may have not affected FC or HR-QOL for up to 60 months (p = 0.15, p = 0.22, respectively). CONCLUSIONS: BTT patients showed long-term preservation of FC and HR-QOL, suggesting that BTT remains an option despite the long waiting time to HTx. - Neoatherosclerosis with silent plaque rupture in a saphenous vein graft causing no re-flow phenomenon assessed by optical coherence tomography and histopathology.
Takao Konishi; Yuki Takahashi; Sho Kazui; Yutaro Yasui; Kohei Saiin; Seiichiro Naito; Sakae Takenaka; Yoshifumi Mizuguchi; Atsushi Tada; Yuta Kobayashi; Kazunori Omote; Takuma Sato; Kiwamu Kamiya; Toshiyuki Nagai; Shinya Tanaka; Toshihisa Anzai
Cardiology journal, 29, 4, 718, 719, 2022年, [国際誌]
英語, 研究論文(学術雑誌) - Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy.
Hiroyuki Natsui; Takao Konishi; Kohei Saiin; Youji Tamaki; Tomoya Sato; Sakae Takenaka; Atsushi Tada; Yoshifumi Mizuguchi; Yuta Kobayashi; Takuma Sato; Rui Kamada; Kiwamu Kamiya; Toshiyuki Nagai; Shinya Tanaka; Toshihisa Anzai
Cardiology journal, 29, 2, 362, 363, 2022年, [国際誌]
英語, 研究論文(学術雑誌) - Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis.
Yuta Kobayashi; Takuma Sato; Toshiyuki Nagai; Kenji Hirata; Satonori Tsuneta; Yoshiya Kato; Hirokazu Komoriyama; Kiwamu Kamiya; Takao Konishi; Kazunori Omote; Hiroshi Ohira; Kohsuke Kudo; Satoshi Konno; Toshihisa Anzai
ESC heart failure, 8, 6, 5282, 5292, 2021年09月12日, [国際誌]
英語, 研究論文(学術雑誌), AIMS: Although soluble interleukin 2 receptor (sIL-2R) is a potentially useful biomarker in the diagnosis and evaluation of disease severity in patients with sarcoidosis, its prognostic implication in patients with cardiac sarcoidosis (CS) is unclear. We sought to investigate whether sIL-2R was associated with clinical outcomes and to clarify the relationship between sIL-2R levels and disease activity in patients with CS. METHODS AND RESULTS: We examined 83 consecutive patients with CS in our hospital who had available serum sIL-2R data between May 2003 and February 2020. The primary outcome was a composite of advanced atrioventricular block, ventricular tachycardia or ventricular fibrillation, heart failure hospitalization, and all-cause death. Inflammatory activity in the myocardium and lymph nodes was assessed by 18 F-fluorideoxyglucose positron emission tomography/computed tomography. During a median follow-up period of 2.96 (IQR 2.24-4.27) years, the primary outcome occurred in 24 patients (29%). Higher serum sIL-2R levels (>538 U/mL, the median) were significantly related to increased incidence of primary outcome (P = 0.037). Multivariable Cox regression analysis showed that a higher sIL-2R was independently associated with an increased subsequent risk of adverse events (HR 3.71, 95% CI 1.63-8.44, P = 0.002), even after adjustment for significant covariates. sIL-2R levels were significantly correlated to inflammatory activity in lymph nodes (r = 0.346, P = 0.003) but not the myocardium (r = 0.131, P = 0.27). CONCLUSIONS: Increased sIL-2R is associated with worse long-term clinical outcomes accompanied by increased systemic inflammatory activity in CS patients. - MitraClipを用いた経皮的僧帽弁接合修復術により強心薬を離脱できた重症心不全の一例
高橋 昌寛; 辻永 真吾; 高橋 勇樹; 佐藤 琢真; 内藤 正一郎; 青柳 裕之; 小林 雄太; 神谷 究; 岩野 弘幸; 永井 利幸; 安斉 俊久
日本心臓病学会学術集会抄録, 69回, O, 267, (一社)日本心臓病学会, 2021年09月
日本語 - Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.
Atsushi Tada; Toshiyuki Nagai; Kazunori Omote; Hiroyuki Iwano; Shingo Tsujinaga; Kiwamu Kamiya; Takao Konishi; Takuma Sato; Hirokazu Komoriyama; Yuta Kobayashi; Sakae Takenaka; Yoshifumi Mizuguchi; Tomoya Sato; Kazuhiro Yamamoto; Tsutomu Yoshikawa; Yoshihiko Saito; Toshihisa Anzai
International journal of cardiology, 342, 43, 48, 2021年08月05日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Diagnosing heart failure with preserved ejection fraction (HFpEF) is challenging. Although the H2FPEF score and HFA-PEFF algorithm have been proposed for diagnosing HFpEF, previous validation studies were conducted in stable chronic heart failure (HF). Moreover, information on their applicability in the Asian population is limited. We sought to investigate these scores' diagnostic performance for HFpEF in Japanese patients recently hospitalized due to acute decompensated HF. METHODS: We examined patients with HFpEF recently hospitalized with acute decompensated HF from a nationwide HFpEF-specific multicenter registry (HFpEF group) and control patients who underwent echocardiography to investigate the cause of dyspnea in our hospital (Non-HFpEF group). RESULTS: The studied population included 372 patients (194 HFpEF group and 178 Non-HFpEF group; HFpEF prevalence, 52%). A high H2FPEF score (6-9 points) could diagnose HFpEF with a high specificity of 97% and a positive predictive value (PPV) of 94%, and a low H2FPEF score (0-1 point) could rule out HFpEF with a high sensitivity of 97% and a negative predictive value (NPV) of 93%. HFpEF could be diagnosed with a high HFA-PEFF score (5-6 points) (specificity, 84%; PPV, 82%) or ruled out with a low HFA-PEFF score (0-1 point) (sensitivity, 99%; NPV, 89%). The H2FPEF score was significantly superior to the HFA-PEFF score in diagnostic accuracy (area under the curve: 0.89 vs. 0.82, respectively, p = 0.004). CONCLUSIONS: The H2FPEF and the HFA-PEFF scores had acceptable diagnostic accuracy in diagnosing HFpEF in Japanese patients. - Blood flow dynamics with four-dimensional flow cardiovascular magnetic resonance in patients with aortic stenosis before and after transcatheter aortic valve replacement.
Hirokazu Komoriyama; Kiwamu Kamiya; Toshiyuki Nagai; Noriko Oyama-Manabe; Satonori Tsuneta; Yuta Kobayashi; Yoshiya Kato; Miwa Sarashina; Kazunori Omote; Takao Konishi; Takuma Sato; Shingo Tsujinaga; Hiroyuki Iwano; Yasushige Shingu; Satoru Wakasa; Toshihisa Anzai
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 23, 1, 81, 81, 2021年06月28日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Pre- and post-procedural hemodynamic changes which could affect adverse outcomes in aortic stenosis (AS) patients who undergo transcatheter aortic valve replacement (TAVR) have not been well investigated. Four-dimensional (4D) flow cardiovascular magnetic resonance (CMR) enables accurate analysis of blood flow dynamics such as flow velocity, flow pattern, wall shear stress (WSS), and energy loss (EL). We sought to examine the changes in blood flow dynamics of patients with severe AS who underwent TAVR. METHODS: We examined 32 consecutive severe AS patients who underwent TAVR between May 2018 and June 2019 (17 men, 82 ± 5 years, median left ventricular ejection fraction 61%, 6 self-expanding valve), after excluding those without CMR because of a contraindication or inadequate imaging from the analyses. We analyzed blood flow patterns, WSS and EL in the ascending aorta (AAo), and those changes before and after TAVR using 4D flow CMR. RESULTS: After TAVR, semi-quantified helical flow in the AAo was significantly decreased (1.4 ± 0.6 vs. 1.9 ± 0.8, P = 0.002), whereas vortical flow and eccentricity showed no significant changes. WSS along the ascending aortic circumference was significantly decreased in the left (P = 0.038) and left anterior (P = 0.033) wall at the basal level, right posterior (P = 0.011) and left (P = 0.010) wall at the middle level, and right (P = 0.012), left posterior (P = 0.019) and left anterior (P = 0.028) wall at the upper level. EL in the AAo was significantly decreased (15.6 [10.8-25.1 vs. 25.8 [18.6-36.2]] mW, P = 0.012). Furthermore, a significant negative correlation was observed between EL and effective orifice area index after TAVR (r = - 0.38, P = 0.034). CONCLUSIONS: In severe AS patients undergoing TAVR, 4D flow CMR demonstrates that TAVR improves blood flow dynamics, especially when a larger effective orifice area index is obtained. - Applicability of the AHA/ACC/HRS Guideline for Implantable Cardioverter Defibrillator Implantation in Japanese Patients With Cardiac Sarcoidosis.
Sakae Takenaka; Yuta Kobayashi; Toshiyuki Nagai; Yoshiya Kato; Hirokazu Komoriyama; Nobutaka Nagano; Kiwamu Kamiya; Takao Konishi; Takuma Sato; Kazunori Omote; Yoshifumi Mizuguchi; Atsushi Tada; Tomoya Sato; Hiroyuki Iwano; Kengo Kusano; Hatsue Ishibashi-Ueda; Toshihisa Anzai
JACC. Clinical electrophysiology, 7, 11, 1410, 1418, 2021年06月22日, [国際誌]
英語, 研究論文(学術雑誌), OBJECTIVES: This study aimed to assess, among Japanese patients with cardiac sarcoidosis (CS), the implantable cardioverter-defibrillator (ICD) recommendations from the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (SCD). BACKGROUND: Although ICDs are used to prevent SCD from ventricular tachycardia or ventricular fibrillation (VT/VF) in patients with CS, the generalizability of the AHA/ACC/HRS guidelines for Japanese patients with CS remains unclear. METHODS: This study examined 188 consecutive patients with CS in 2 tertiary hospitals between 1979 and 2020. Patients were followed for a primary outcome of VT/VF or SCD. RESULTS: During a median follow-up of 5.68 years, the primary outcome occurred in 44 patients (23%). Patients with a class I recommendation for ICD implantation showed the highest incidence of the primary outcome among patients in whom the guideline recommendations for ICD implantation were used (log-rank test; p = 0.03). However, compared with patients with left ventricular ejection fractions (LVEFs) ≤35%, there was no significant difference in the incidence of the primary outcome among patients with LVEFs >35% and those who required a permanent pacemaker (p = 0.31); similar results were observed in those with LVEFs >35% and late gadolinium enhancement during cardiovascular magnetic resonance imaging (p = 0.22). CONCLUSIONS: The American guideline recommendations for ICD implantation might be applicable to Japanese patients with CS. Implantation of an ICD may need to be considered in these patients if they require a permanent pacemaker or have late gadolinium enhancement, regardless of LVEF. - Long-Term Prognostic Significance of Ventricular Repolarization Dispersion in Patients with Cardiac Sarcoidosis.
Yuta Kobayashi; Toshiyuki Nagai; Sakae Takenaka; Yoshiya Kato; Hirokazu Komoriyama; Nobutaka Nagano; Kiwamu Kamiya; Takao Konishi; Takuma Sato; Kazunori Omote; Shingo Tsujinaga; Hiroyuki Iwano; Kengo Kusano; Satoshi Yasuda; Hisao Ogawa; Hatsue Ishibashi-Ueda; Toshihisa Anzai
The American journal of cardiology, 152, 125, 131, 2021年06月11日, [国際誌]
英語, 研究論文(学術雑誌), Cardiac sarcoidosis (CS) is frequently complicated by fatal ventricular arrhythmias. T-peak to T-end interval to QT interval ratio (TpTe/QT) on electrocardiograms (ECG) was proposed as a marker of ventricular repolarization dispersion. Although this ratio could be associated with the incidence of ventricular arrhythmias in cardiovascular diseases, its prognostic implication in patients with CS is unclear. We sought to investigate whether TpTe/QT was associated with long-term clinical outcomes in patients with CS. Ninety consecutive patients with CS in 2 tertiary hospitals who had ECG data before initiation of immunosuppressive therapy between November 1995 and March 2019 were examined. The primary outcome was a composite of advanced atrioventricular block, ventricular tachycardia or ventricular fibrillation (VT/VF), heart failure hospitalization, and all-cause death. During a median follow-up period of 4.70 (interquartile range 2.06-7.23) years, the primary outcome occurred in 21 patients (23.3%). Survival analyses revealed that the primary outcome (p < 0.001), especially VT/VF or sudden cardiac death (p = 0.002), occurred more frequently in patients with higher TpTe/QT (≥ 0.242, the median) than in those with lower TpTe/QT. Multivariable Cox regression analysis showed that a higher TpTe/QT was independently associated with increased subsequent risk of adverse events (hazard ratio1.11, 95% confidence interval 1.03-1.20, p = 0.008) even after adjustment for the significant covariates. In conclusion, a higher TpTe/QT was associated with worse long-term clinical outcomes, especially fatal ventricular arrhythmic events, in patients with cardiac sarcoidosis, suggesting the importance of assessing TpTe/QT as a surrogate for risk stratification in these patients. - Prognostic value of admission serum magnesium in acute myocardial infarction complicated by malignant ventricular arrhythmias.
Yoshifumi Mizuguchi; Takao Konishi; Toshiyuki Nagai; Tomoya Sato; Sakae Takenaka; Atsushi Tada; Yuta Kobayashi; Hirokazu Komoriyama; Yoshiya Kato; Kazunori Omote; Takuma Sato; Kiwamu Kamiya; Shingo Tsujinaga; Hiroyuki Iwano; Kenjiro Kikuchi; Shinya Tanaka; Toshihisa Anzai
The American journal of emergency medicine, 44, 100, 105, 2021年06月, [国際誌]
英語, 研究論文(学術雑誌), OBJECTIVES: Although electrolyte abnormalities are related to worse clinical outcomes in patients with acute myocardial infarction (AMI), little is known about the association between admission serum magnesium level and adverse events in AMI patients complicated by out-of-hospital cardiac arrest presenting with malignant ventricular arrhythmias (OHCA-MVA). We investigated the prognostic value of serum magnesium level on admission in these patients. METHODS: We retrospectively analyzed the data of 165 consecutive reperfused AMI patients complicated with OHCA-MVA between April 2007 and February 2020 in our university hospital. Serum magnesium concentration was measured on admission. The primary outcome was in-hospital death. RESULTS: Fifty-four patients (33%) died during hospitalization. Higher serum magnesium level was significantly related to in-hospital death (Fine & Gray's test; p < 0.001). In multivariable logistic regression analyses, serum magnesium level on admission was independently associated with in-hospital death (hazard ratio 2.68, 95% confidence interval 1.24-5.80) even after adjustment for covariates. Furthermore, the incidences of cardiogenic shock necessitating an intra-aortic balloon pump (p = 0.005) or extracorporeal membrane oxygenation (p < 0.001), tracheal intubation (p < 0.001) and persistent vegetative state (p = 0.002) were significantly higher in patients with higher serum magnesium level than in those with lower serum magnesium level. CONCLUSIONS: In reperfused AMI patients complicated by OHCA-MVA, admission serum magnesium level might be a potential surrogate marker for predicting in-hospital death. - 4-Dimensional Flow Cardiovascular Magnetic Resonance Imaging of Changes in Blood Flow Dynamics After Surgery for Discrete Subaortic Stenosis.
Hirokazu Komoriyama; Kiwamu Kamiya; Yuta Kobayashi; Satonori Tsuneta; Takao Konishi; Takuma Sato; Hiroyuki Iwano; Toshiyuki Nagai; Satoru Wakasa; Kohsuke Kudo; Toshihisa Anzai
Circulation journal : official journal of the Japanese Circulation Society, 85, 6, 954, 954, 2021年05月25日, [国内誌]
英語, 研究論文(学術雑誌) - Acute Myocardial Infarction of the Left Main Coronary Artery Presenting with Cardiogenic Shock and Pulmonary Edema during Noncardiac Surgery.
Sakae Takenaka; Takao Konishi; Tomoya Sato; Atsushi Tada; Takuya Koizumi; Yoshifumi Mizuguchi; Takahide Kadosaka; Ko Motoi; Yuta Kobayashi; Hirokazu Komoriyama; Yoshiya Kato; Miwa Sarashina; Kazunori Omote; Shingo Tsujinaga; Takuma Sato; Rui Kamada; Kiwamu Kamiya; Hiroyuki Iwano; Toshiyuki Nagai; Tatsuya Orimo; Hirofumi Kamachi; Akinobu Taketomi; Toshihisa Anzai
Case reports in cardiology, 2021, 5460816, 5460816, 2021年, [国際誌]
英語, Acute myocardial infarction (AMI) caused by severe stenosis of left main coronary artery (LMCA) presenting with cardiogenic shock and pulmonary edema during noncardiac surgery is uncommon, but a catastrophic event. A 77-year-old male with cholangiocarcinoma underwent hepatectomy. During the surgery, he presented with cardiogenic shock, which did not respond to infusion administration or vasopressor. A transesophageal echocardiogram revealed anterior, septal, and lateral severe hypokinesia and impaired left ventricular function. Emergent coronary angiogram showed severe stenosis of LMCA. The patient underwent primary percutaneous coronary intervention (PCI) under the support of intra-aortic balloon pump, followed by extracorporeal membrane oxygenation. The chest roentgenogram showed pulmonary edema. Two days after PCI, he successfully underwent hepatectomy and bile duct resection. Early identification of the cause of hemodynamic instability during noncardiac surgery and invasive strategy are important for minimizing the myocardial injury and improving clinical outcomes in AMI of LMCA. - The effectiveness of drug-coated balloons for two dissimilar calcific lesions assessed by near-infrared spectroscopy intravascular ultrasound and optical coherence tomography.
Takao Konishi; Kohei Saiin; Youji Tamaki; Hiroyuki Natsui; Tomoya Sato; Sakae Takenaka; Atsushi Tada; Yoshifumi Mizuguchi; Yuta Kobayashi; Hirokazu Komoriyama; Yoshiya Kato; Takuma Sato; Rui Kamada; Kiwamu Kamiya; Toshiyuki Nagai; Shinya Tanaka; Toshihisa Anzai
Cardiology journal, 28, 5, 794, 795, 2021年, [国際誌]
英語, 研究論文(学術雑誌) - Lower left ventricular ejection fraction and higher serum angiotensin-converting enzyme activity are associated with histopathological diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis.
Hirokazu Komoriyama; Kazunori Omote; Toshiyuki Nagai; Yoshiya Kato; Nobutaka Nagano; Kazuhiro Koyanagawa; Kiwamu Kamiya; Takao Konishi; Takuma Sato; Yuta Kobayashi; Shingo Tsujinaga; Hiroyuki Iwano; Kengo Kusano; Satoshi Yasuda; Hisao Ogawa; Hatsue Ishibashi-Ueda; Toshihisa Anzai
International journal of cardiology, 321, 113, 117, 2020年12月15日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: The histopathological diagnosis of cardiac sarcoidosis (CS) is challenging because of sampling error in endomyocardial biopsy (EMB) and the determinants of positive EMB are unclear. Reduced left ventricular ejection fraction (LVEF) is a simple parameter of the extent of myocardial damage, and higher serum angiotensin-converting enzyme (ACE) activity would indicate the spread of disease activity in CS patients. Thus, we sought to examine whether these parameters are related to the histopathological diagnosis of CS by EMB. METHODS: A total of 94 consecutive clinically diagnosed CS patients between August 1986 and March 2019 who were admitted to two academic hospitals were examined. We determined EMB as positive if non-caseating epithelioid granulomas were confirmed in the myocardial tissue. Patients were divided into two groups according to positive (n = 37) and negative (n = 57) EMB. We assessed the relationship between LVEF, serum ACE activity and positive EMB. RESULTS: Multivariable analysis revealed that both LVEF and serum ACE were independently associated with positive EMB (OR 0.83, 95% CI 0.70-0.99; OR 1.39, 95% CI 1.02-1.90, respectively). Moreover, patients with both lower LVEF (<37%, median) and higher ACE activity (≥13.5 IU/L, median) had the highest frequency of positive EMB (p = .003). The combination of lower LVEF and higher serum ACE showed better specificity (91.2%) and positive predictive value (73.7%) than either LVEF or serum ACE alone for positive EMB. CONCLUSIONS: Lower LVEF and higher serum ACE activity were associated with positive EMB, suggesting that these parameters might be useful for predicting positive EMB in CS patients. - 心臓サルコイドーシス患者におけるステロイド開始前心室再分極過程のばらつきは長期心事故発生と関連する
小林 雄太; 永井 利幸; 神谷 究; 小西 崇夫; 佐藤 琢真; 加藤 喜哉; 小森山 弘和; 草野 研吾; 植田 初江; 安斉 俊久
日本サルコイドーシス/肉芽腫性疾患学会雑誌, 40, サプリメント号, 56, 56, 日本サルコイドーシス, 2020年10月
日本語 - 心臓サルコイドーシス患者でfragmented QRSは、心事故、慢性期致死性不整脈と関連する
萩原 光; 渡邉 昌也; 中尾 元基; 甲谷 太郎; 小林 雄太; 加藤 喜哉; 小森山 弘和; 鎌田 塁; 永井 利幸; 安斉 俊久
日本サルコイドーシス/肉芽腫性疾患学会雑誌, 40, サプリメント号, 56, 56, 日本サルコイドーシス, 2020年10月
日本語 - Myocardial T1-mapping and Extracellular Volume Quantification in Patients and Putative Carriers of Muscular Dystrophy: Early Experience.
Kazuhiro Koyanagawa; Yuta Kobayashi; Tadao Aikawa; Atsuhito Takeda; Hideaki Shiraishi; Satonori Tsuneta; Noriko Oyama-Manabe; Hiroyuki Iwano; Toshiyuki Nagai; Toshihisa Anzai
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 20, 3, 320, 324, 2020年09月07日, [国内誌]
英語, 研究論文(学術雑誌), To assess myocardial fibrosis associated with muscular dystrophy, T1-mapping and extracellular volume fraction (ECV) quantification was prospectively performed using cardiovascular MR (CMR) imaging in 6 male patients with muscular dystrophy and 5 female putative carriers of Duchenne or Becker muscular dystrophy. Five patients and all putative carriers had an elevated ECV (>29.5% for men and >35.2% for women), suggesting that ECV has a potential to detect diffuse fibrotic changes in patients and putative carriers of muscular dystrophy. - Usefulness of Liver Magnetic Resonance Elastography for Estimating Right-Atrial Pressure in Heart Failure Patients.
Yoshiya Kato; Toshiyuki Nagai; Noriko Oyama-Manabe; Satonori Tsuneta; Michikazu Nakai; Yuta Kobayashi; Hirokazu Komoriyama; Kazunori Omote; Shingo Tsujinaga; Takuma Sato; Takao Konishi; Kiwamu Kamiya; Hiroyuki Iwano; Toshihisa Anzai
JACC. Cardiovascular imaging, 13, 9, 2050, 2052, 2020年09月, [国際誌]
英語 - Refractory Right Ventricular Failure in a Patient with Emery-Dreifuss Muscular Dystrophy.
Yasuyuki Chiba; Arata Fukushima; Motoki Nakao; Yuta Kobayashi; Takahiro Ishigaki; Taro Tenma; Kiwamu Kamiya; Yasushige Shingu; Tomonori Ooka; Yoshiro Matsui; Toshihisa Anzai
Internal medicine (Tokyo, Japan), 59, 10, 1277, 1281, 2020年05月15日, [国内誌]
英語, 研究論文(学術雑誌), A 23-year-old man had progressive muscle weakness and Emery-Dreifuss muscular dystrophy (EDMD) due to a LMNA (lamin A/C) mutation. Congestive heart failure diagnosed at 19 years of age. Maximal drug treatment/cardiac resynchronization failed to improve the cardiac function. He was therefore hospitalized due to heart failure. Despite extracorporeal membrane oxygenation, he developed severe right heart dysfunction and died (multiple organ failure). A cardiac lesion's presence determines the prognosis of EDMD. While there are many arrhythmia reports, few reports on heart failure (particularly severe heart failure requiring cardiac transplantation) have been published. Right heart function monitoring and early ventricular-assist device use plus right heart support considering heart transplantation are important. - VISUALIZATION OF PERIPROCEDUAL BLOOD FLOW DYNAMICS WITH FOUR-DIMENSIONAL FLOW MAGNETIC RESONANCE IMAGING IN PATIENTS WITH SEVERE AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
Hirokazu Komoriyama; Kiwamu Kamiya; Toshiyuki Nagai; Noriko Oyama-Manabe; Satonori Tsuneta; Yuta Kobayashi; Yoshiya Kato; Kazunori Omote; Takao Konishi; Takuma Sato; Shingo Tsujinaga; Hiroyuki Iwano; Yasushige Shingu; Satoru Wakasa; Toshihisa Anzai
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75, 11, 1639, 1639, 2020年03月
英語 - Prognostic Value of Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction (from the Japanese Nationwide Multicenter Registry).
Yuta Kobayashi; Kazunori Omote; Toshiyuki Nagai; Kiwamu Kamiya; Takao Konishi; Takuma Sato; Yoshiya Kato; Hirokazu Komoriyama; Shingo Tsujinaga; Hiroyuki Iwano; Kazuhiro Yamamoto; Tsutomu Yoshikawa; Yoshihiko Saito; Toshihisa Anzai
The American journal of cardiology, 125, 5, 772, 776, 2020年03月01日, [国際誌]
英語, 研究論文(学術雑誌), Elevated serum uric acid (UA) is associated with an increased risk of cardiovascular disease and worse clinical outcome in patients with cardiovascular disease. Nevertheless, the prognostic value of serum UA level in hospitalized heart failure patients with preserved ejection fraction (HFpEF) has not been fully elucidated. The aim of this study was to investigate whether serum UA level on admission could be associated with subsequent mortality in hospitalized patients with HFpEF. We examined 516 consecutive hospitalized HFpEF (left ventricular ejection fraction ≥50%) patients with decompensated heart failure from our HFpEF-specific multicenter registry who had serum UA data on admission. The primary outcome of interest was all-cause death. During a median follow-up period of 749 (interquartile range 540 to 831) days, 90 (17%) patients died. Higher serum UA level was significantly related to increased incidence of all-cause death (p = 0.016). In addition, patients with higher serum UA (≥6.6 mg/dl, median) and plasma B-type natriuretic peptide (≥401.2 pg/ml, median) levels had the highest incidence of all-cause death in the groups (p = 0.002). In multivariable Cox regression analysis, serum UA was an independent determinant of mortality (hazards ratio 1.23, 95% confidence interval 1.10 to 1.39) even after adjustment for prespecified confounders, renal function and the use of diuretics before admission. In conclusions, higher admission serum UA was an independent determinant of mortality in hospitalized HFpEF patients. Our findings indicate the importance of assessing admission serum UA level for further risk stratification in hospitalized patients with HFpEF. - Left ventricular outflow tract velocity time integral in hospitalized heart failure with preserved ejection fraction.
Kazunori Omote; Toshiyuki Nagai; Hiroyuki Iwano; Shingo Tsujinaga; Kiwamu Kamiya; Tadao Aikawa; Takao Konishi; Takuma Sato; Yoshiya Kato; Hirokazu Komoriyama; Yuta Kobayashi; Kazuhiro Yamamoto; Tsutomu Yoshikawa; Yoshihiko Saito; Toshihisa Anzai
ESC heart failure, 7, 1, 167, 175, 2020年02月, [国際誌]
英語, 研究論文(学術雑誌), AIMS: The prognostic implication of left ventricular outflow tract velocity time integral (LVOT-VTI) on admission in hospitalized heart failure with preserved ejection fraction (HFpEF) patients has not been determined. We sought to investigate whether LVOT-VTI on admission is associated with worse clinical outcomes in hospitalized patients with HFpEF. METHODS AND RESULTS: We studied consecutive 214 hospitalized HFpEF patients who had accessible LVOT-VTI data on admission, from a prospective HFpEF-specific multicentre registry. The primary outcome of interest was the composite of all-cause death and readmission due to heart failure. During a median follow-up period of 688 (interquartile range 162-810) days, the primary outcome occurred in 83 patients (39%). The optimal cut-off value of LVOT-VTI for the primary outcome estimated by receiver operating characteristic analysis was 15.8 cm. Lower LVOT-VTI was significantly associated with the primary outcome compared with higher LVOT-VTI (P = 0.005). Multivariable Cox regression analyses revealed that lower LVOT-VTI was an independent determinant of the primary outcome (hazard ratio 0.94, 95% confidence interval 0.91-0.98). In multivariable linear regression, haemoglobin level was the strongest independent determinant of LVOT-VTI among clinical parameters (β coefficient = -0.61, P = 0.007). Furthermore, patients with lower LVOT-VTI and anaemia had the worst clinical outcomes among the groups (P < 0.001). CONCLUSIONS: Lower admission LVOT-VTI was an independent determinant of worse clinical outcomes in hospitalized HFpEF patients, indicating that LVOT-VTI on admission might be useful for categorizing a low-flow HFpEF phenotype and risk stratification in hospitalized HFpEF patients. - Histopathologically confirmed very late stent thrombosis associated with stent fracture after implantation of first-generation drug eluting stent.
Takao Konishi; Naohiro Funayama; Tadashi Yamamoto; Daisuke Hotta; Yuta Kobayashi; Hirokazu Komoriyama; Yoshiya Kato; Kazunori Omote; Takuma Sato; Kiwamu Kamiya; Toshiyuki Nagai; Shinya Tanaka; Toshihisa Anzai
Cardiology journal, 27, 2, 204, 205, 2020年, [国際誌]
英語, 研究論文(学術雑誌) - Emery-Dreifuss muscular dystrophy as a possible cause of coronary embolism.
Atsushi Tada; Takao Konishi; Takuma Sato; Tomoya Sato; Takuya Koizumi; Sakae Takenaka; Yoshifumi Mizuguchi; Takahide Kadosaka; Ko Motoi; Yuta Kobayashi; Hirokazu Komoriyama; Yoshiya Kato; Kazunori Omote; Shingo Tsujinaga; Rui Kamada; Kiwamu Kamiya; Hiroyuki Iwano; Toshiyuki Nagai; Nanase Okazaki; Yoshihiro Matsuno; Toshihisa Anzai
Cardiology journal, 27, 4, 443, 444, 2020年, [国際誌]
英語, 研究論文(学術雑誌) - Increased Liver Stiffness Assessed by Magnetic Resonance Elastography Predicts Elevated Right Atrial Pressure in Patients With Heart Failure
Yoshiya Kato; Toshiyuki Nagai; Noriko Oyama-Manabe; Satonori Tsuneta; Yuta Kobayashi; Hirokazu Komoriyama; Kazunori Omote; Shingo Tsujinaga; Tadao Aikawa; Takuma Sato; Takao Konishi; Kiwamu Kamiya; Hiroyuki Iwano; Toshihisa Anzai
CIRCULATION, 140, 2019年11月
英語 - Prognostic Value of Admission Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction: A Report From the Japanese Real-world Multicenter Registry
Yuta Kobayashi; Kazunori Omote; Toshiyuki Nagai; Kiwamu Kamiya; Tadao Aikawa; Takao Konishi; Takuma Sato; Hiroyuki Iwano; Shingo Tsujinaga; Yoshiya Kato; Hirokazu Komoriyama; Kazuhiro Yamamoto; Tsutomu Yoshikawa; Yoshihiko Saito; Toshihisa Anzai
CIRCULATION, 140, 2019年11月
英語 - Reduced Left Ventricular Ejection Fraction and Higher Angiotensin-Converting Enzyme Levels as Key Determinants of Histopathologic Diagnosis by Endomyocardial Biopsy in Patients With Cardiac Sarcoidosis
Hirokazu Komoriyama; Kazunori Omote; Toshiyuki Nagai; Yuta Kobayashi; Yoshiya Kato; Takuma Sato; Takao Konishi; Tadao Aikawa; Kiwamu Kamiya; Kazuhiro Koyanagawa; Shingo Tsujinaga; Hiroyuki Iwano; Hatsue Ueda; Toshihisa Anzai
CIRCULATION, 140, 2019年11月
英語
- 房室結節アブレーション,CRT-D植え込み術,経皮的僧帽弁接合不全修復術のHybrid治療でドブタミンを離脱し得た重症心不全の一例
濱谷孟志; 小林雄太; 森勇喜; 佐藤琢真; 天満太郎; 神谷究; 永井利幸; 安斉俊久, 日本心臓病学会学術集会(Web), 71st, 2023年 - 心臓サルコイドーシス患者における血清可溶性インターロイキン2レセプター高値は長期予後と関連する
小林雄太; 永井利幸; 平田健司; 常田慧徳; 加藤喜哉; 小森山弘和; 神谷究; 小西崇夫; 佐藤琢真; 表和徳; 工藤與亮; 今野哲; 安斉俊久, 日本サルコイドーシス/肉芽腫性疾患学会雑誌, 41, 2021年 - MRIのT1mappingによる心筋細胞外容積分画は筋ジストロフィーによるびまん性心筋障害の検出に有用である
相川忠夫; 小梁川和宏; 小林雄太; 武田充人; 白石秀明; 常田慧徳; 岩野弘幸; 永井利幸; 安斉俊久; 真鍋徳子, 日本心血管画像動態学会プログラム・抄録集, 31st (CD-ROM), 2021年 - 心臓サルコイドーシス患者でfragmented QRSは、心事故、慢性期致死性不整脈と関連する
萩原 光; 渡邉 昌也; 中尾 元基; 甲谷 太郎; 小林 雄太; 加藤 喜哉; 小森山 弘和; 鎌田 塁; 永井 利幸; 安斉 俊久, 日本サルコイドーシス/肉芽腫性疾患学会雑誌, 40, サプリメント号, 56, 56, 2020年10月
日本サルコイドーシス, 日本語 - 心臓サルコイドーシス患者におけるステロイド開始前心室再分極過程のばらつきは長期心事故発生と関連する
小林 雄太; 永井 利幸; 神谷 究; 小西 崇夫; 佐藤 琢真; 加藤 喜哉; 小森山 弘和; 草野 研吾; 植田 初江; 安斉 俊久, 日本サルコイドーシス/肉芽腫性疾患学会雑誌, 40, サプリメント号, 56, 56, 2020年10月
日本サルコイドーシス, 日本語 - 心腎連関(心臓の観点から) (特集 腎臓と他臓器連関を考える : CKDにおける包括的治療戦略を目指して) -- (臓器連関の実態)
小林 雄太; 安斉 俊久, 内科 = Internal medicine : 臨床雑誌, 126, 2, 181, 183, 2020年08月
南江堂, 日本語 - エイコサペンタエン酸治療と冠動脈プラーク安定性の関連性についての検討 光干渉断層診断法を用いた検討
小西 崇夫; 小林 雄太; 小森山 弘和; 加藤 喜哉; 表 和徳; 相川 忠夫; 佐藤 琢真; 神谷 究; 永井 利幸; 須永 大介; 舟山 直宏; 山本 匡; 堀田 大介; 安斉 俊久, 日本心血管インターベンション治療学会抄録集, 28回, [MO6, 001], 2019年09月
(一社)日本心血管インターベンション治療学会, 英語 - 心電図同期SPECTが虚血領域評価に有用であった冠動脈バイパス術後の1例
小林 雄太; 相川 忠夫; 永井 利幸; 神谷 究; 小西 崇夫; 佐藤 琢真; 表 和徳; 加藤 喜哉; 小森山 弘和; 安斉 俊久, 日本心血管インターベンション治療学会抄録集, 28回, [MP15, 003], 2019年09月
(一社)日本心血管インターベンション治療学会, 英語 - 心不全患者におけるMagnetic Resonance Elastographyを用いた肝硬度測定による右房圧推定の有用性
加藤 喜哉; 永井 利幸; 小林 雄太; 小森山 弘和; 表 和徳; 相川 忠夫; 佐藤 琢真; 小西 崇夫; 神谷 究; 安斉 俊久, 日本心臓病学会学術集会抄録, 67回, O, 315, 2019年09月
(一社)日本心臓病学会, 日本語 - 心不全患者におけるMagnetic Resonance Elastographyを用いた肝硬度測定による右房圧推定の有用性
加藤 喜哉; 永井 利幸; 小林 雄太; 小森山 弘和; 表 和徳; 相川 忠夫; 佐藤 琢真; 小西 崇夫; 神谷 究; 安斉 俊久, 日本心臓病学会学術集会抄録, 67回, O, 315, 2019年09月
(一社)日本心臓病学会, 日本語 - エイコサペンタエン酸治療と冠動脈プラーク安定性の関連性についての検討 光干渉断層診断法を用いた検討
小西 崇夫; 小林 雄太; 小森山 弘和; 加藤 喜哉; 表 和徳; 相川 忠夫; 佐藤 琢真; 神谷 究; 永井 利幸; 須永 大介; 舟山 直宏; 山本 匡; 堀田 大介; 安斉 俊久, 日本心血管インターベンション治療学会抄録集, 28回, [MO6, 001], 2019年09月
(一社)日本心血管インターベンション治療学会, 英語 - 心電図同期SPECTが虚血領域評価に有用であった冠動脈バイパス術後の1例
小林 雄太; 相川 忠夫; 永井 利幸; 神谷 究; 小西 崇夫; 佐藤 琢真; 表 和徳; 加藤 喜哉; 小森山 弘和; 安斉 俊久, 日本心血管インターベンション治療学会抄録集, 28回, [MP15, 003], 2019年09月
(一社)日本心血管インターベンション治療学会, 英語 - 大動脈弁形成を意識した心エコー 弁輪拡大による大動脈弁閉鎖不全の要因に関する検討 3D経食道エコーの計測精度
村井 大輔; 小松 博史; 鈴木 里穂; 小林 雄太; 小森山 弘和; 鳥羽 真弘; 浅川 響子; 檀ノ浦 裕; 牧野 隆雄; 甲谷 哲郎, 超音波医学, 44, Suppl., S201, S201, 2017年04月
(公社)日本超音波医学会, 日本語 - 大動脈内血栓症を合併した感染性心内膜炎の一例
鈴木 理穂; 鳥羽 真弘; 小林 雄太; 加藤 喜哉; 山梨 克真; 浅川 響子; 檀浦 裕; 小松 博史; 松井 裕; 牧野 隆雄; 甲谷 哲郎, 市立札幌病院医誌, 76, 1, 77, 81, 2016年10月
市立札幌病院, 日本語 - BTK領域における創治癒につながるinterventionとは何か? 当院での治療成績から考える
檀浦 裕; 鈴木 理穂; 小林 雄太; 加藤 喜哉; 鳥羽 真弘; 山梨 克真; 浅川 響子; 小松 博史; 松井 裕; 牧野 隆雄; 甲谷 哲郎, 日本心血管インターベンション治療学会抄録集, 25回, np2, np2, 2016年07月
(一社)日本心血管インターベンション治療学会, 日本語 - EVTによるOne straight lineが得られなかったものの、創治癒に至ったCLIの一例
檀浦 裕; 堀内 勝己; 小林 雄太; 鈴木 理穂; 加藤 喜哉; 鳥羽 真弘; 山梨 克真; 浅川 響子; 小松 博史; 松井 裕; 牧野 隆雄; 甲谷 哲郎, 日本下肢救済・足病学会誌, 8, 2, 92, 92, 2016年05月
日本下肢救済・足病学会, 日本語 - 心臓サルコイドーシスの診断に18F-FDG PETが有用であった一例
馬場 菜月; 鳥羽 真弘; 鈴木 理穂; 小林 雄太; 加藤 喜哉; 山梨 克真; 浅川 響子; 檀浦 裕; 小松 博史; 松井 裕; 牧野 隆雄; 甲谷 哲郎, 市立札幌病院医誌, 75, 2, 255, 259, 2016年03月
市立札幌病院, 日本語 - 若年女性に発症した急性心筋梗塞の1例
鈴木 理穂; 小林 雄太; 加藤 喜哉; 山梨 克真; 鳥羽 真弘; 浅川 響子; 檀浦 裕; 小松 博史; 松井 裕; 牧野 隆雄; 甲谷 哲郎, 市立札幌病院医誌, 75, 1, 61, 66, 2015年10月
市立札幌病院, 日本語 - 腸管切除を伴うヘルニア修復術に人工物の留置は可能である
小林 雄太; 倉内 宣明; 砂原 正男; 常俊 雄介; 鍵谷 卓司; 大橋 大成; 笠島 浩行; 原 豊; 鈴木 伸作; 遠山 茂; 木村 純, 日本臨床外科学会雑誌, 75, 9, 2636, 2636, 2014年09月
日本臨床外科学会, 日本語
- 心臓サルコイドーシスにおける多角的画像評価を用いた新規予後指標の探索
科学研究費助成事業 若手研究
2023年04月01日 - 2026年03月31日
小林 雄太
日本学術振興会, 若手研究, 北海道大学, 23K15090
